SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-088662
Filing Date
2016-01-07
Accepted
2016-01-07 16:24:45
Documents
3
Period of Report
2016-01-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-25723_58k.htm 8-K 35847
2 EX-1.1 a15-25723_5ex1d1.htm EX-1.1 291637
3 EX-5.1 a15-25723_5ex5d1.htm EX-5.1 14621
  Complete submission text file 0001104659-16-088662.txt   343293
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 161330490
SIC: 2834 Pharmaceutical Preparations